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Background: Population ageing is a global phenomenon that has characterised demographic trends during the
20th and 21st century. The rapid growth in the proportion of older adults in the population, and resultant increase
in the incidence of age-related cognitive decline, dementia and Alzheimer’s disease, brings significant social,
economic and healthcare challenges. Decline in cognitive abilities represents the most profound threat to active
and healthy ageing. Current evidence suggests that a significant proportion of cases of age-related cognitive decline
and dementia may be preventable through the modification of risk factors including education, depressive
symptomology, physical activity, social engagement and participation in cognitively stimulating activities. The
NEIL Memory Research Unit cohort study was established to investigate factors related to brain health and the
maintenance of cognitive function.
Methods: A cohort of 1000 normally ageing adults aged 50 years and over are being recruited to participate in
comprehensive assessments at baseline, and at follow-up once every 2 years. The assessment protocol comprises
a comprehensive neuropsychological battery, some basic physical measures, psychosocial scales, questionnaire
measures related to a range of health, lifestyle and behavioural factors, and a measure of resting state activity
using electroencephalography (EEG).
Discussion: The NEIL Memory Research Unit cohort study will address key questions about brain health and
cognitive ageing in the population aged 50+, with a particular emphasis on the influence of potentially
modifiable factors on cognitive outcomes. Analyses will be conducted with a focus on factors involved in the
maintenance of cognitive function among older adults, and therefore will have the potential to contribute
significant knowledge related to key questions within the field of cognitive ageing, and to inform the
development of public health interventions aimed at preventing cognitive decline and promoting active and
healthy ageing.
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Population ageing is a global phenomenon that has char-
acterised demographic trends during the 20th and 21st
century, and presents both opportunities and challenges
to society (Park & Reuter-Lorenz 2009). While an ageing
population brings opportunities linked to the wealth of
knowledge and experience possessed by older citizens;
the increasing health, social and financial support needs
of older adults place a significant societal burden in terms
of healthcare and socio-economic provision. In almost all
regions of the world, older adults represent the fastest
growing proportion of the population, with the 60+ age
group projected to be growing 3.5 times as rapidly as the
total population by 2025–2030 (United Nations Popula-
tion Division 2001). In Ireland, the proportion of the
population aged 65+, which was stable at 11 % for the past
40 years, is predicted to reach 22 % by 2041 (McGill 2010;
Layte 2009). Perhaps one of the most formidable chal-
lenges associated with an ageing population is the poten-
tial for considerably increased incidence of age-related
cognitive impairment. Advancing age is the greatest risk
factor for neurodegenerative disorders such as Alzheimer’s
disease (AD) and other dementias (Mangialasche et al.
2012). The health and social cost of dementia disorders is
considerable, with dementia care currently costing more
than heart disease, stroke and cancer care combined. The
current cost of dementia services per annum is estimated
at €160 billion in Europe and €1.69 billion in Ireland.
These estimates do not account for the concomitant psy-
chological and social impact that dementia disorders have
on individuals and caregivers.
Much of the cognitive decline experienced by older
adults is not due to specific dementia pathologies
(Henderson 2014); and normal, non-pathological ageing is
associated with more subtle decline in a number of
cognitive domains including executive functioning, speed
of processing, memory, language and psychomotor ability
(Buckner 2004). Age-related cognitive impairment that
does not reach the threshold for dementia diagnosis is as-
sociated with reduced quality of life, increased health-care
costs, increased neuropsychiatric symptoms, increased
disability and increased risk for progression to dementia
(Albert et al. 2002; Lyketsos et al. 2002; Edland et al. 2002).
Cognition is critical for mental and physical health,
and social and emotional wellbeing. In turn, physical
health, psychological health and degree of social engage-
ment affect cognitive health. As treatments to delay on-
set and reduce incidence of heart disease, cancer and
stroke become increasingly available, neurodegenerative
conditions and cognitive decline are set to become one
of the leading causes of mortality in an ageing population
(Depp et al. 2012). Among the growing number of individ-
uals aged 65+, the prospect of experiencing cognitive de-
cline that results in a loss of independence is reported asone of the most feared aspects of the ageing process, and
neurocognitive frailty is currently considered to be the
greatest obstacle to successful, active and healthy ageing
(Park & Reuter-Lorenz 2009; Daffner 2010).
The nature and severity of cognitive changes that occur
with age are heterogeneous, ranging from essentially
preserved functioning observed in individuals who are
sometimes referred to as “super-elderly”, to the severe
impairments observed in individuals diagnosed with
dementing disorders (Daffner 2010; Anderson 2008).
The different trajectories of cognitive decline observed
among older adults are not related to one common
process of “brain ageing”, but rather result from dis-
tinct cascades associated with non-pathological ageing
and neurodegenerative disease states (Anderson 2008).
The observation that some individuals live into old age
with minimal decline, together with increasing evidence
for brain plasticity in response to environment and ex-
perience across the lifespan, has sparked considerable
global interest in understanding how older adults can main-
tain cognitive function. Preventing cognitive decline is cru-
cial in order to extend independent living and promote
active and healthy ageing. The identification of preventative
strategies to maintain cognitive health can be considered a
key priority for the reduction of age-associated disability
and morbidity (Depp et al. 2012).
While further research is needed, current evidence – pri-
marily from observational and epidemiological studies –
suggests that a range of both genetic and environmental
factors influence individual cognitive trajectories and cog-
nitive decline during ageing (Mangialasche et al. 2012). It is
likely that a multitude of factors contribute to the inter-
individual differences observed in age-related cognitive
outcomes. Potential risk and protective factors include
ApoE status, midlife hypertension, depressive symptomol-
ogy, education, socio-economic status, occupational attain-
ment, dietary patterns, social engagement, participation in
cognitively stimulating activities, and health behaviours
such as physical activity and not smoking (Mangialasche
et al. 2012; Stern 2012; Barnes & Yaffe 2011). It has
been suggested that approximately half of all cases of
Alzheimer’s disease worldwide may be attributable to
known risk factors, a number of which are modifiable,
raising the possibility that some of these cases may be
preventable through risk factor modification (Yaffe
et al. 2014). Prevention of cognitive decline and dementia
is a legitimate, evidence based approach, and epidemio-
logical research supports the possibility of reducing de-
mentia prevalence and age-specific incidence through
addressing modifiable risk factors (Cleary & McAvoy
2014). In an important review paper, Barnes & Yaffe (2011)
suggested that a 10-25 % reduction in all of seven poten-
tially modifiable risk factors – diabetes, midlife hyper-
tension, midlife obesity, smoking, depression, cognitive
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activity – could prevent up to 1.1 to 3 million AD cases
worldwide.
A large number of longitudinal studies have been estab-
lished to investigate the relationship of a range of factors
to cognitive decline in older adults, including, for example,
the Rush Memory and Ageing Project, the Nun Study, the
Victoria Longitudinal Study, the Health and Retirement
Study (HRS), the English Longitudinal Study of Ageing
(ELSA) and the Maastricht Ageing Study. In addition to
risk factors for cognitive decline and dementia, longitu-
dinal studies can identify protective factors associated with
the maintenance of cognitive function among participants
considered to exhibit “successful ageing”. The identifica-
tion of such risk and protective factors has the potential to
inform public health interventions aimed at reducing
disability, improving quality of life and decreasing social,
healthcare and economic challenges associated with an
ageing population.
The NEIL (Neuro-Enhancement for Independent
Lives) Memory Research Unit was established to follow
a large group of normally ageing adults in Ireland, in
order to address key questions about factors involved in
brain health and the maintenance of cognitive function
in the face of age-related neural changes, with a particu-
lar focus on the impact of potentially modifiable risk and
protective factors on cognitive trajectories among our
ageing cohort. The study protocol was designed to in-
clude some parallel measures to The Irish Longitudinal
Study of Ageing (TILDA) (TILDA 2010), a nationally
representative study of adults aged 50+, in order to allow
for comparability with national norms generated from
the TILDA dataset. The Memory Research Unit protocol
contains a more comprehensive cognitive battery than
was feasible for inclusion in the TILDA study, and there-
fore allows for more detailed investigations of cognitive
function in a similar population.
Aims
The aims of the study are:
1. To establish a cohort of healthy older adults (aged
50+) who are willing to engage in research related to
cognitive ageing on an ongoing basis.
2. To establish the cognitive profile of each participant
at baseline through comprehensive
neuropsychological evaluation, and to track changes
in these cognitive profiles over time by means of
repeat assessment.
3. To examine, in detail, cognitive trajectories and
outcomes as the cohort ages and their associations
with biological, social, lifestyle, behavioural and
psychological factors. The longitudinal element of
the study will focus on factors contributing to themaintenance of brain health and cognitive function
in this age group.
4. To advance understanding of risk and protective
factors related to cognitive ageing.
Methods/Design
Study design
We aim to recruit a total cohort of 1,000 participants aged
50 and over to this longitudinal observational study at
baseline, and will invite these participants to complete
follow-up assessments every 2 years. The study develop-
ment, baseline and wave 1 follow-up phases of the
study are currently supported using funds from a larger
grant by the Atlantic Philanthropies, PhD Scholarships
funded by the Irish Research Council, the Irish State-
funded JobBridge internship scheme and voluntary hours
undertaken by study investigators and associates. The
study will continue until 2018, and we are actively seeking
funding to extend the study duration and support add-
itional waves of follow-up assessment beyond this date.
The study plan involves a number of phases, including a
study development period, recruitment phase, and base-
line and follow-up assessment waves; and allows for over-
lap between waves in order to maximise the available
resources and facilitate the greatest throughput of research
participants. The current study schedule as proposed for
the period 2011–2017 is illustrated in Fig. 1. A full list of
the variables assessed and instruments used at each assess-
ment wave is included in Table 1. The measures included
in the protocol were selected through detailed literature re-
views and consultation with a group clinical and academic
ageing experts, in order to ensure the most appropriate
measures were used for each construct. The study design
is graphically represented in Fig. 2.
To date, over 1,000 individuals have registered interest
in taking part in the study, and 693 participants have
completed baseline assessments. Baseline descriptive sta-
tistics for the sample tested to date are provided in
Table 2. The first wave of follow-up testing began in July
2014, and as of December 2014 86 participants have
been invited for follow-up assessment with a retention
rate of 81.4 %.
Ethical considerations
All study procedures are approved and authorised by the
School of Psychology Research Ethics Committee (SPREC)
at Trinity College Dublin. Written, informed consent is ob-
tained from all participants, and participants are free to
withdraw from the study at any time. Participants can also
withdraw their data from the study at any point after they
have completed assessments. All data is stored under a
unique study ID code, without participant names or other
identifying information. The study is non-invasive and im-
poses no significant risks.
Fig. 1 NEIL Memory Research Unit study timeline
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The cohort is recruited from members of the general pub-
lic in the Republic of Ireland who are aged over 50 years,
in good health, and are in a position to attend Trinity Col-
lege Dublin for an assessment session once every 2 years.
Potential participants are provided with information about
the study through advertisements, articles and interviews
with the study investigators in local and national media
(radio and print); community based information sessions
provided by the study team; announcements in newslet-
ters and circulars of relevant age-related organisations (for
example Age Action Ireland, Active Retirement Ireland);
through existing networks with ageing organisations; and
at national conferences and events. Following receipt of
this information, individuals can contact the study team in
order to register their interest in taking part in the study.
Each potential participant receives a postal information
pack that includes an introduction letter, a study informa-
tion leaflet, consent forms and a stamped addressed enve-
lope. Any individual who decides to take part in the study
returns the signed consent forms by post, and is then con-
tacted to complete an initial brief telephone interview.
The purpose of this phone interview is two-fold: it is de-
signed to collect information relating to history of a range
of health conditions, family history of AD/dementia and a
full list of the medications taken on a regular basis by the
participant; and it also serves as a screening interview,
with items included to specifically determine whether the
participant meets any of the study exclusion criteria. The
phone interview includes items from the Christensen
Health Screening Questionnaire (Christensen et al. 1992)
with some minor adaptations, along with additional items
generated by the study investigators. An inventory of all
current medications and long-term prescriptions are col-
lected by asking the participant to read verbatim the
name, dosage and frequency of each medication from the
labels/boxes. The inclusion criteria imposed at baseline
are: resident in the Republic of Ireland and in a position
to travel to Trinity College for assessment, aged at least
50 years, and fluent in English to a standard sufficient for
completion of neuropsychological assessment. Exclusion
criteria are history of stroke, epilepsy, major psychiatric
disorder, drug or alcohol abuse within the past 5 years,
current use of anti-psychotic or anti-epileptic medication,self-report of significant memory problems or dementia,
or problems with vision or hearing that would prevent
neuropsychological evaluation.
Baseline assessment
Following the initial telephone screening interview, all
participants who do not meet any exclusion criteria are
sent questionnaires to be completed at home prior to their
assessment, and scheduled for a baseline assessment ses-
sion. The postal questionnaire contains detailed demo-
graphic items along with scales to measure social, lifestyle
and behavioural factors. Information collected in this
questionnaire includes date of birth, marital status, occu-
pational status and history, information about caregiving,
self-rated health and memory, alcohol use and smoking
behaviour, loneliness (De Jong & Van Tilburg 2006), sleep
quality (Buysse et al. 1989), and participation in leisure ac-
tivities (House et al. 1982). Participants are also sent a
copy of the IQCODE (Informant Questionnaire for Cogni-
tive Decline in the Elderly) (Jorm 1994), for a close relative
or friend to complete.
Baseline assessment sessions take place at the NEIL
Memory Research Unit in Trinity College Dublin. The
assessment protocol entails a detailed assessment of cog-
nitive function, psychosocial, behavioural, physical and
physiological factors by means of:
a) Cognitive assessment battery
Cognitive function is assessed using a 16 item battery
of neuropsychological and experimental measures (see
Table 1). The tests included in this battery were selected
to provide measures of global cognition, along with func-
tioning in a number of domains including episodic mem-
ory, working memory, prospective memory, executive
function, speed, and attention. The WRAT-3 Reading
subtest (Wilkenson 1993) was included as a screen for
dyslexia or reading difficulties. The NART (National Adult
Reading Test) (Nelson 1982) was included to provide an
estimate of premorbid function.
b) Psychosocial scales and questionnaires
Depressive symptoms, anxiety, perceived stress, life satis-
faction, quality of life and social network are assessed
using the scales detailed in Table 1. Physical activity was














Explain Study X X





Medical history Health Screening
Questionnaire
(Christensen et al. 1992)
X






Self-report item X X
Self-rated health Self-report items X X
Frailty Fried Frailty Index
(Fried et al. 2001)
X X
Cognitive function
Self-rated memory Self-report items X X
Subjective memory
complaints/ failures – self-
rated
MAC-Q (Crook et al. 1992) X




IQCODE (Jorm 1994) X X
Proxy PRMQ (P-PRMQ)








Premorbid IQ NART (Nelson 1982) X
Overall function MMSE (Folstein et al. 1975) X X
MoCA (Nasreddine et al. 2005) X X
Episodic Memory WMS-IV Logical Memory
Subtest (Weschler 2009)
X X
Bushke & Grober FCSRT
(Grober & Buschke 1987)
X X
ACAD word and shape
recognition task – immediate
and delayed recall
(Di Rosa et al. 2014)
X X




Prospective Memory TILDA Experimental Task X X
Processing Speed Colour Trails 1






Executive Function Colour Trails 2
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Table 1 Schedule of assessments and measures (Continued)
CAMDEX Visual
Reasoning Subtest





(Robertson et al. 1997)
X X
ACAD Shapes Sustained
Attention to Response (SSART)
task (Di Rosa et al. 2014)
X X
Visuo-Spatial Landmark Spatial
Bias Task (20 item)
(Bellgrove et al. 2005)
X
Demographics
Age Self-report item X X X X
Sex Self-report item X
Marital Status Self-report item X X
Occupational Status –
current
Self-report items X X
Occupational History Items adapted from
Cognitive Reserve




Years of education, highest
level completed – self report
X X
Caregiving Self-report items X X
Behavioural/lifestyle
Smoking Self-report items X X
Alcohol Use Self-report items X X
CAGE
(Mayfield et al. 1974)
X X
Sleep Quality Pittsburgh Sleep
Quality Index
(Buysse et al. 1989)
X X
Stanford Sleepiness
Scale(Hoddes et al. 1973)
X X
Physical Activity IPAQ – Short Form









(Wilson et al. 2013)
X
Boredom-proneness Self-report item





Self-report item X X
Depression CES-D Scale (Radloff 1977) X X
Anxiety HADS-A Anxiety subscale
(Zigmond & Snaith 1983)
X X
Perceived Stress 4-item Perceived
Stress Scale (PSS-4)
(Cohen et al. 1983)
X X
CASP-12 (Wiggins et al. 2008) X X
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Table 1 Schedule of assessments and measures (Continued)
Quality of Life/Life
Satisfaction







Scale – 18-item (LSNS-18)
(Lubben et al. 2003)
X
Physical
Height Standing body height –
Seca® stadiometer
X X
Weight Weight – Seca®electronic
scale
X X
Dominant hand Self-report X X
Walking Speed Timed walk – 16 ft
(4.8768 m)
X X





EEG - Resting State 3 min eyes open, 3
min eyes closed
X X
ACAD Automated Cognitive Assessment Delivery; CAMDEX Cambridge Mental Disorders of the Elderly Examination; CES-D Centre for Epidemiologic Studies
Depression Scale; FCSRT Free and Cued Selective Reminding Test; HADS-A Hospital Anxiety and Depression Scale; IPAQ International Physical Activity Questionnaire
IQCODE Informant Questionnaire for Cognitive Decline in the Elderly; LSNS-18 Lubben Social Network Scale (18 item); MAC-Q Memory Assessment Clinic
Questionnaire; MMSE Mini-Mental State Examination; MoCA Montreal Cognitive Assessment; NART National Adult Reading Test; PRMQ Prospective Retrospective
Memory Questionnaire; PSS-4 Perceived Stress Scale (4 item); SART Sustained Attention to Response Task; SSART Shapes Sustained Attention to Response Task;
TILDA The Irish Longitudinal Study of Ageing; WMS Weschler Memory Scale; WRAT-3 Wide Range Achievement Test 3
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Physical Activity Questionnaire (Craig et al. 2003), which
provides an objective measure of energy expenditure
(MET-minutes per week) as well as a categorical measure
of physical activity level (low, medium, high).
c) Basic physical measures and function tests
Standing body height (cm) is measured using a stadi-
ometer (Seca® - 216). Weight (kg) is evaluated with an
electronic scale (Seca® - 876). Hand-grip strength (kg) is
measured using a Baseline® Hydraulic Hand Dynamom-
eter (Standard), with two readings taken from each hand.
Walking speed (s/ms) is measured over a distance of
16 ft (4.8768 m). Frailty classifications are generated for
each participant using the Fried Index (Fried et al. 2001).
d) Electroencephalogram
Electroencephalography is used to collect a measure of
resting state brain activity. EEG measures were included
in order to collect direct measures of brain activity with-
out the expense or necessary exclusions of methods such
as MRI. The EEG data will be used in order to investi-
gate potential electrophysiological markers of age-related
cognitive decline. Spectral analysis of EEG recordingshave proved to be promising potential biomarkers of
cognitive deficits in recent studies (Moretti et al. 2013).
EEG signals are recorded using an ActiveTwo system
(BioSemi, The Netherlands) from 32 surface electrodes.
EEG recordings are collected while the participant sits at
rest with their eyes closed for 3 minutes, and their eyes
open for 3 minutes.
All baseline measures are collected during one assess-
ment session lasting approximately 2.5-3 hours including
regular breaks to avoid participant fatigue. All research ses-
sions take place at either 10am or 2pm, in order to allow
for statistical control for time of day effects. All measures
are administered in the same order to each participant,
using strict standard operating procedures and scripts to
ensure consistency of the testing process. Data is entered
directly to an automated, custom-built interface via a lap-
top computer during testing.
The full protocol was tested in a pilot study (n = 20)
and shown to be fully practical and practicable. The
schedule was shown to be acceptable to participants.
Based on feedback from pilot participants, a number of
grammatical and structural changes were made to the
postal questionnaire in order to improve readability and
ease of completion.
Fig. 2 NEIL Memory Research Unit study design
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Table 2 Descriptive statistics for current baseline sample
N 693












CES-D ≥16, % 8
Self-rated health
Excellent, % 25.4
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All participants are invited to complete a follow-up as-
sessment every 2 years. Assessment procedures will be
identical for each follow-up wave. A full list of variables
assessed and instruments used during follow-up waves is
detailed in Table 1. Follow-up assessments follow a simi-
lar structure to the baseline evaluation – consisting of a
phone interview, questionnaires to be completed by the
participant and an informant at home, and one assess-
ment session at Trinity College Dublin.
During the follow-up phone interview, information is
collected about significant health changes since baseline
assessment, health conditions, family history of AD/de-
mentia, and smoking and alcohol use. Any participant
who reports a change in their smoking behaviour orTable 3 Age distribution of Irish population aged 50+ in 2011
Censusa





Total population aged 50+ 1,273,087
Total population 4,588,252
aData for these calculations was taken from the “Profile 2: Older and Younger”
report of the 2011 Census of Ireland (Central Statistics Office 2011)alcohol use are asked to provide more detailed informa-
tion by repeating measures related to these variables that
were administered at baseline. An inventory of medica-
tions is again collected using the identical procedures to
baseline assessment.
The postal questionnaire completed by participants at
follow-up repeats all items from the baseline question-
naire, with the exception of occupational history, in
order to allow for assessment of change in these factors
over time. The original baseline questionnaire items are
supplemented with additional items and scales designed
to collect more detailed information about subjective
memory ratings, complaints (Crook et al. 1992) and fail-
ures (Smith et al. 2000); along with an additional social
network scale (Lubben et al. 2003), and an additional ac-
tivities scale that assesses participation in cognitively-
stimulating activities across the lifespan (Wilson et al.
2013). Participants are again sent an informant question-
naire, to be completed by a close friend or relative, at
each follow-up assessment point. This questionnaire re-
peats the IQCODE (Jorm 1994) from baseline, and is
supplemented with additional items designed to assess
subjective ratings of the participant’s memory perform-
ance (compared to others their age, change since their
last assessment, decline in memory), and with the in-
formant version of the Prospective Retrospective Memory
Questionnaire (PRMQ) (Smith et al. 2000).
The follow-up assessment session follows an almost
identical protocol to the baseline assessment, repeating all
measures with the exception of the National Adult Read-
ing Test and the WRAT-3 Reading sub-test. One add-
itional task designed to measure spatial bias is included at
the end of the cognitive battery during follow-up assess-
ments. All measures are again collected during one assess-
ment session, lasting approximately 2.5-3 hours including
breaks.
Sample size considerations
Following protocol design from previous studies of similar
nature (e.g.(Collerton et al. 2007)), we considered formal
sample size calculations for the study as a whole to be un-
feasible, given that there are a large number of specific fac-
tors to be analysed. The target sample size was selected
based on a number of considerations, including sample
sizes used in previous studies of a similar design which
proved sufficient for a range of statistically significant con-
clusions to be drawn. The sample size was also selected
based on pilot recruitment and testing, to account for the
number of participants that could feasibly be recruited
and tested per year with the resources available.
Table 3 details the age distribution of the population
of Ireland aged 50+, based on data from the 2011 Cen-
sus (Central Statistics Office 2011), which can be used to
provide some indication of the expected age distribution
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of the Irish population was aged over 50 years. The age
distribution of our baseline sample recruited to date (see
Table 2) shows that in our current sample, participants
aged 60–69 are over-represented, and participants aged
50–59 and 80+ are under-represented. The proportion
of participants aged 70–79 is largely in line with what
would be expected based on the Census data in Table 1.
We will attempt to address these issues in future recruit-
ment, perhaps by targeting recruitment activity towards
age groups that are currently under-represented. These
issues may also be addressed with statistical weighting in
future analyses.
While statistical consideration of attrition was not
feasible, attrition rates from a number of nationally rep-
resentative longitudinal ageing studies provide some in-
dication of the level of attrition that might be expected
in our study. For example, among participants aged 55–
64 years, 88 % of participants in the HRS, and 68 % of
participants in ELSA responded to all three assessment
waves in the period 2002–2006 (Banks et al. 2011). For
participants aged 70–80 years, the percentage who
responded to all three waves during the same period was
78 % in the HRS and 63 % in ELSA (Banks et al. 2011).
Preliminary data on attrition rates TILDA, which com-
pletes follow-up assessments every 2 years, shows a total
response rate of 86 % at wave 2 (Nolan et al. 2014).
While acknowledging that our current estimations are
based on a small number of participants, the retention
rate currently observed for our first wave of follow-up is
largely in line with that of TILDA and is encouraging in
terms of potential impact of attrition rates.
Planned statistical analyses
Interim analyses will take place after the completion of
each study phase. Descriptive analyses based on means,
standard deviations, percentages, relative risks and 95 %
confidence intervals will be used to describe the studied
population. Given the comprehensive nature of the data-
set collected, a wide range of analyses will be conducted
to investigate individual research questions using subsets
of the variables available, and specific analysis plans will
be generated for each research question of interest. These
specific analysis plans are beyond the scope of this paper
and will be described fully in subsequent publications.
Upon completion of baseline assessment, cross-sectional
analyses will be conducted to explore relationships be-
tween various factors measured and cognitive performance
among the cohort. These cross sectional analyses will in-
clude logistic regression models and structural equation
modelling techniques. As follow up data becomes available
full analysis of the data will be conducted using multivari-
ate statistical methods in order to model the effects of a
range of predictor variables on cognitive trajectories. Whendata is available for 2 time-points, these analyses will in-
clude, for example, mixed models analyses and weighted
analysis of covariance models with appropriate covariates
of baseline measures and age and gender. Once data be-
comes available for 3 time-points, methods including linear
growth curve modelling will be employed. Relevant covari-
ates will be included as interaction terms.
Specific analysis plans will be designed to include statis-
tical consideration of methodological issues related to lon-
gitudinal data collection, including missing data, practice
effects, regression to the mean and attrition. For example,
an attrition weight (inverse-probability) based on drop out
from follow-up wave 1, using key variables of interest such
as age, comorbidities and frailty, will be calculated and ap-
plied to subsequent analyses. In dealing with missing data,
we intend to use methods including multiple imputation
and Full Information Maximum Likelihood (FIML) esti-
mation, depending on the specific analysis plan for the re-
search question under investigation.
The primary outcomes of interest will be cognitive func-
tion measured at baseline, and change in cognitive func-
tion measured longitudinally. To limit the number of
dependent variables and improve robustness of underlying
cognitive constructs, raw test scores will be converted into
Z scores using baseline sample means and standard devia-
tions, and the average of these Z scores will be used to
create a measure of global cognitive functioning. The
measures will also be grouped into domains (e.g. episodic
memory, executive function, attention, processing speed),
and the average Z score for measures included in each do-
main will be calculated as a composite measure. The
grouping of measures into domains will be guided by pre-
vious literature and exploratory factor analysis of our data.
In the primary analysis, if data is available for the majority
of tests that make up a domain score (e.g. 3 out of 5, or 2
out of 3 tests), data will be combined as described above
and included. A sensitivity analysis including only cases
with complete data for all cognitive measures will be con-
ducted to investigate the impact of missing values.
Quality control
Standardisation and training
The study is managed by a core team of senior investiga-
tors, and data collection is conducted by a team of re-
search assistants who are recruited via state-funded
internship schemes, volunteer psychology graduates and
postgraduate students in the School of Psychology at
Trinity College Dublin. Given that neuropsychological
assessment and data collection will be completed by a
team of research assistants, standardisation of protocols
and rigorous training are a critical priority in order to
ensure the validity of the data collected. Strict standard
operating procedures for all data collection and input ac-
tivities have been developed, including a detailed testing
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tion of all measures. All research assistants complete a
comprehensive training program before beginning data
collection, including a one day training course, practice
research sessions, and a validation session where they
are approved for testing by a senior investigator.
Data entry and processing - control, traceability and valid-
ation of results
All study data is recorded via a custom-built, automated,
secure web-based system, following a strict standard op-
erating procedure. This system was designed to reduce
the level of human error in raw data entry – the user-
friendly interface only allows values that lie within the
correct possible range to be entered for each measure,
and includes inbuilt checks for data completeness and
validity – for instance, pop-up windows to remind the
researcher of the correct time lag for delayed recall
tasks, or to notify the researcher if any data is missing
before saving. Encoding and initial processing of the col-
lected data is automatically conducted by this system,
which was designed, developed and rigorously tested by
Trinity Centre for High Performance Computing (TCHPC)
in collaboration with the senior investigators. The data
entry system retains revision logs in order to allow trace-
ability. Data is then exported from this system to .csv files
for further processing and analysis – all steps taken to
further process, clean or recode data are verified by two
or even three people involved at specific stages of the
procedure.
Follow-up and participant retention
In order to encourage continued participation and involve-
ment with the study, participants are sent quarterly news-
letters containing an update on study progress, along with
information about other activities within our larger re-
search program. They are also invited to events organised
by the NEIL programme, such as Brain Health Awareness
evenings or information talks. All enrolled participants re-
ceive a postal information pack every two years, inviting
them to return for a follow-up assessment. One week after
this information pack is sent, a research assistant contacts
the participant by phone to discuss the information they
have received, re-explain the study and arrange a follow-up
appointment. Participants are asked to sign a form con-
firming their continuing consent to take part in the study
before each follow-up assessment.
Dissemination
Results will be disseminated at regional, national and
international research conferences; in reports published by
our research programme and in articles published in inter-
national peer-reviewed journals.Discussion
The NEIL Memory Research Unit cohort study will ad-
dress key questions about brain health and cognitive age-
ing in the Irish population aged 50+, with a particular
focus on the influence of potentially modifiable factors –
such as physical activity, cognitive reserve, psychological
health, social engagement or cognitively stimulating activ-
ities – on cognitive outcomes among an ageing popula-
tion. The comprehensive nature of the data collected will
allow for investigation of a range of key questions related
to cognitive ageing. One of the main objectives of the
study is to identify factors that are associated with differ-
ent cognitive trajectories experienced by older adults.
Regular follow-up assessments will allow for identification
of this variability in individual cognitive trajectories among
our cohort, and examination of their associations with a
range of health, behavioural, psychosocial and lifestyle fac-
tors. Analyses will be conducted with a focus on factors
involved in the maintenance of cognitive function among
older adults, and therefore will have the potential to in-
form future intervention studies.
The study design has a number of strengths. Detailed
neuropsychological evaluation of participants at each
time point will facilitate exploration of specific cognitive
profiles, and of the relationship of these profiles to a
range of outcomes and predictors. Rigorous quality con-
trol procedures incorporated within the study protocol
from the outset, including detailed standard operating
procedures and automated systems to reduce error in
data entry and processing, will ensure that the dataset
produced is of high quality and validity. Published and
highly-cited measures with established reliability and val-
idity were selected whenever possible.
Given that our sample is self-selecting, it is likely to be
biased towards high-functioning, well-educated, motivated
volunteers – as is the case in many studies of cognitive
ageing (Nebes et al. 2006). Preliminary descriptive analysis
shows that a large majority of the sample recruited to date
have completed third level education, suggesting that our
total sample will have a disproportionate number of highly
educated participants, which may limit the generalizability
of our results to less-educated populations. Evidence from
the cognitive reserve literature suggests that education
may act as a ‘buffer’ against cognitive impairment, allow-
ing highly educated individuals to tolerate a greater level
of neuropathology before experiencing clinical symptoms
of dementia (Stern 2012). As such, highly educated older
adults may represent a uniquely ‘at risk’ group, given
that subtle early cognitive decline may be difficult to
detect using traditional norm-based neuropsychological
approaches, and that the ‘window of opportunity’ for
intervention may have passed by the time clinical impair-
ment is detected. We therefore consider them to be a group
of particular interest in terms of our research objectives,
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our sample. We have included detailed measures of a range
of cognitive reserve indicators within our study protocol
that will permit comprehensive investigation of factors that
contribute to reserve across the lifespan, and allow us to
model the effects of cognitive reserve using multiple proxy
indicators. This has not been possible in other studies that
have used education as a single indicator to represent cog-
nitive reserve.
A further issue related to a self-selecting sample is the
over-representation of individuals between 60 and 69 years
in the distribution of participants recruited to date, which
again may limit the generalizability of the study results and
may also have an impact in terms of the length of follow
up required to detect cognitive change. We may address
this issue with statistical weighting in future analyses, and
also by targeting future recruitment activities towards
under-represented age groups.
The use of a self-report medical history and relatively
minimal exclusion criteria may also result in a sample in-
cluding participants with health conditions that are not se-
vere enough to prevent their participation in the study, but
are known risk factors for neuropathology and likely to
affect cognitive performance (Nebes et al. 2006). Indeed,
there is considerable debate in the literature as to whether
exclusion criteria for studies of older adults should be de-
signed for the selection of a perfectly healthy sample,
which could be described as ‘super-elderly’; or one that is
more representative of a general population (Tisserand &
Jolles 2003). Having considered this literature, our prefer-
ence was for a sample more representative of the normally
ageing population of Ireland aged 50+, many of whom will
have health conditions or engage in behaviours that could
influence cognition. Thus, our criteria were selected to
achieve a balance between importance and practicality, ex-
cluding participants who had medical conditions or were
taking medications that would be expected to have a sig-
nificant impact on cognitive performance, without exclud-
ing an inordinate proportion of the population.
Unfortunately due to resource limitations, it was not
possible for us to include collection of some potentially
useful data types, such as blood chemistry, genetic mea-
sures or scanning, in the design of this study. These
measures have been included in a number of previous
longitudinal studies, and certainly would have added
considerable value to our dataset had their inclusion
been feasible. We acknowledge that the absence of these
data types represents a limitation of our study. Given
that one of the aims of this project was to establish a co-
hort of older adults willing to engage in cognitive ageing
research on an ongoing basis, we included within our
consent procedures an ‘opt in’ for participants who
would be interested in being contacted to take part in
further add-on studies from time to time. This provisionhas allowed for the possibility of collecting additional
useful measures such as blood chemistry or neuroimag-
ing, from at least a subset of our sample should funding
become available to do so, and to analyse this additional
data along with the data currently collected as part of
the design of the main study detailed here.
This study will generate new knowledge to increase our
understanding of cognitive ageing adding to data that has
emerged from large longitudinal studies across the globe.
As stated above, the study runs in parallel with TILDA,
and the protocol contains a number of measures that are
common to both studies. The characteristics of our self-
selecting sample suggest that it is likely to contain a higher
proportion of successfully ageing individuals with high cog-
nitive reserve than the TILDA sample. Comparisons of
outcomes among these two samples may add to knowledge
relating to the effects of cognitive reserve, the efficacy
of neuropsychological assessments in identifying cogni-
tive decline among high performers as compared with
the general population, and the potential risks associ-
ated with under-detection of cognitive decline among
high performing individuals. In addition, the design of
our study allows us to run sub-studies to collect add-
itional data types from our participants, which may
allow for investigation of additional research questions
or interventions based on findings that emerge from
the TILDA study.
Our study protocol contains measures of a number of
variables that were identified, in a comprehensive review
of longitudinal studies of ageing, as important for future
investigation (Stanziano et al. 2010). For example, it was
suggested that BMI and gait speed may emerge as an
important index for prediction of health status and mor-
tality (Stanziano et al. 2010), and the inclusion of these
measures in our protocol will allow this potential index
to be investigated as a predictor of cognitive decline.
The authors also noted that while factors associated with
socioeconomic status are routinely measured in longitu-
dinal ageing studies, it remains unclear whether these
factors are associated with functional status, cognitive out-
comes and mortality (Stanziano et al. 2010). Our protocol
contains detailed measures of occupational status and
educational history across the lifespan, which will be in-
vestigated in relation to cognitive outcomes.
The identification of factors involved in the mainten-
ance of cognitive health, with a view to developing pub-
lic health intervention approaches, is a key priority for
research aiming to address social, healthcare and eco-
nomic challenges associated with demographic ageing.
We believe that the data collected as part of this study
has the potential to contribute important knowledge that
is required to answer fundamental questions related to
cognitive ageing, which will have major long-term rele-
vance for the health of our rapidly ageing population.
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